» Articles » PMID: 35194940

All-cause Versus Cause-specific Excess Deaths for Estimating Influenza-associated Mortality in Denmark, Spain, and the United States

Abstract

Background: Seasonal influenza-associated excess mortality estimates can be timely and provide useful information on the severity of an epidemic. This methodology can be leveraged during an emergency response or pandemic.

Method: For Denmark, Spain, and the United States, we estimated age-stratified excess mortality for (i) all-cause, (ii) respiratory and circulatory, (iii) circulatory, (iv) respiratory, and (v) pneumonia, and influenza causes of death for the 2015/2016 and 2016/2017 influenza seasons. We quantified differences between the countries and seasonal excess mortality estimates and the death categories. We used a time-series linear regression model accounting for time and seasonal trends using mortality data from 2010 through 2017.

Results: The respective periods of weekly excess mortality for all-cause and cause-specific deaths were similar in their chronological patterns. Seasonal all-cause excess mortality rates for the 2015/2016 and 2016/2017 influenza seasons were 4.7 (3.3-6.1) and 14.3 (13.0-15.6) per 100,000 population, for the United States; 20.3 (15.8-25.0) and 24.0 (19.3-28.7) per 100,000 population for Denmark; and 22.9 (18.9-26.9) and 52.9 (49.1-56.8) per 100,000 population for Spain. Seasonal respiratory and circulatory excess mortality estimates were two to three times lower than the all-cause estimates.

Discussion: We observed fewer influenza-associated deaths when we examined cause-specific death categories compared with all-cause deaths and observed the same trends in peaks in deaths with all death causes. Because all-cause deaths are more available, these models can be used to monitor virus activity in near real time. This approach may contribute to the development of timely mortality monitoring systems during public health emergencies.

Citing Articles

Influenza-Related Deaths in the Czech Republic Over 21 Seasons.

Kyncl J, Brabec M, Maly M, Simka V, Urban A Influenza Other Respir Viruses. 2025; 19(3):e70072.

PMID: 40045909 PMC: 11883282. DOI: 10.1111/irv.70072.


Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018.

Schindler C, Wittenberg I, Damm O, Kramer R, Mikolajczyk R, Schonfelder T Infect Dis Ther. 2024; 13(11):2333-2350.

PMID: 39298083 PMC: 11499578. DOI: 10.1007/s40121-024-01043-9.


Uncovering the burden of Influenza in children in Portugal, 2008-2018.

Afonso A, Gouveia C, Januario G, Carmo M, Lopes H, Bricout H BMC Infect Dis. 2024; 24(1):100.

PMID: 38238649 PMC: 10797867. DOI: 10.1186/s12879-023-08685-z.


Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities.

Moa A, Kunasekaran M, Akhtar Z, Costantino V, MacIntyre C Hum Vaccin Immunother. 2023; 19(3):2271304.

PMID: 37929779 PMC: 10629430. DOI: 10.1080/21645515.2023.2271304.


Excess mortality among people with communicable diseases over a 30-year period, Victoria, Australia: a whole of population cohort study.

Rowe S, Leder K, Sundaresan L, Wollersheim D, Lawrie J, Stephens N Lancet Reg Health West Pac. 2023; 38:100815.

PMID: 37790083 PMC: 10544289. DOI: 10.1016/j.lanwpc.2023.100815.


References
1.
Iuliano A, Roguski K, Chang H, Muscatello D, Palekar R, Tempia S . Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2017; 391(10127):1285-1300. PMC: 5935243. DOI: 10.1016/S0140-6736(17)33293-2. View

2.
van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, Meijer A, van der Hoek W . Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis. 2012; 206(5):628-39. DOI: 10.1093/infdis/jis415. View

3.
Nielsen J, Vestergaard L, Richter L, Schmid D, Bustos N, Asikainen T . European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?. Clin Microbiol Infect. 2019; 25(10):1266-1276. DOI: 10.1016/j.cmi.2019.02.011. View

4.
Simonsen L, Viboud C . The art of modeling the mortality impact of winter-seasonal pathogens. J Infect Dis. 2012; 206(5):625-7. DOI: 10.1093/infdis/jis419. View

5.
Schmidt S, Iuliano A, Vestergaard L, Mazagatos-Ateca C, Larrauri A, Brauner J . All-cause versus cause-specific excess deaths for estimating influenza-associated mortality in Denmark, Spain, and the United States. Influenza Other Respir Viruses. 2022; 16(4):707-716. PMC: 9178070. DOI: 10.1111/irv.12966. View